BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572
20 results:

  • 1. Genome-wide association study of actinic keratosis identifies new susceptibility loci implicated in pigmentation and immune regulation pathways.
    Kim Y; Yin J; Huang H; Jorgenson E; Choquet H; Asgari MM
    Commun Biol; 2022 Apr; 5(1):386. PubMed ID: 35449187
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Indurated Plaques on the Legs: Think Lymphoma.
    Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epigenetic Alterations in Keratinocyte Carcinoma.
    Yao Q; Epstein CB; Banskota S; Issner R; Kim Y; Bernstein BE; Pinello L; Asgari MM
    J Invest Dermatol; 2021 May; 141(5):1207-1218. PubMed ID: 33212152
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating foxp1.
    Sun HW; Yang GL; Wang SN; Zhang YJ; Ding JX; Zhang XN
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8991-8999. PubMed ID: 31696487
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nuclear pseudoinclusions in melanoma cells: prognostic fact or artifact? The possible role of Golgi phosphoprotein 3 overexpression in nuclear pseudoinclusions generation.
    Donizy P; Kaczorowski M; Biecek P; Halon A; Matkowski R
    Pathol Int; 2018 Feb; 68(2):117-122. PubMed ID: 29377340
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nucleoli cytomorphology in cutaneous melanoma cells - a new prognostic approach to an old concept.
    Donizy P; Biecek P; Halon A; Maciejczyk A; Matkowski R
    Diagn Pathol; 2017 Dec; 12(1):88. PubMed ID: 29284501
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Foxo1 and foxp1 play opposing roles in regulating the differentiation and antitumor activity of T
    Bi E; Ma X; Lu Y; Yang M; Wang Q; Xue G; Qian J; Wang S; Yi Q
    Sci Signal; 2017 Oct; 10(500):. PubMed ID: 29018172
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Spontaneous Regression After Biopsy.
    Marrero-Alemán G; Montenegro-Dámaso T; Peñate Y
    Am J Dermatopathol; 2017 Oct; 39(10):785-787. PubMed ID: 28926365
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.
    Asgari MM; Wang W; Ioannidis NM; Itnyre J; Hoffmann T; Jorgenson E; Whittemore AS
    J Invest Dermatol; 2016 May; 136(5):930-937. PubMed ID: 26829030
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
    Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.
    Santucci M; Grandi V; Maio V; Delfino C; Alterini R; Pimpinelli N
    G Ital Dermatol Venereol; 2012 Dec; 147(6):581-8. PubMed ID: 23149704
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.
    Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O
    J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma.
    Demirkesen C; Tüzüner N; Esen T; Lebe B; Ozkal S
    Leuk Res; 2011 Sep; 35(9):1269-72. PubMed ID: 21700336
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. foxp1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
    Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
    Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
    Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
    Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma.
    Hoefnagel JJ; Mulder MM; Dreef E; Jansen PM; Pals ST; Meijer CJ; Willemze R; Vermeer MH
    Mod Pathol; 2006 Sep; 19(9):1270-6. PubMed ID: 16778825
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients.
    Kodama K; Massone C; Chott A; Metze D; Kerl H; Cerroni L
    Blood; 2005 Oct; 106(7):2491-7. PubMed ID: 15947086
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.